Screening for novel genes of Saccharomyces cerevisiae involved in recombinant antibody production.

about

Screening for novel genes of Saccharomyces cerevisiae involved in recombinant antibody production.

Item

http://www.wikidata.org/entity/Q36221124

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Screening for novel genes of S ...... combinant antibody production.

@ast

Screening for novel genes of S ...... combinant antibody production.

@en

type

Item

label

Screening for novel genes of S ...... combinant antibody production.

@ast

Screening for novel genes of S ...... combinant antibody production.

@en

prefLabel

Screening for novel genes of S ...... combinant antibody production.

@ast

Screening for novel genes of S ...... combinant antibody production.

@en

P1476

Screening for novel genes of S ...... combinant antibody production.

@en

P2093

German Jurgens

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of an ERAD gene as VPS30/ATG6 reveals two alternative and functionally distinct protein quality control pathways: one for soluble Z variant of human alpha-1 proteinase inhibitor (A1PiZ) and another for aggregates of A1PiZ.

Functional profiling of the Saccharomyces cerevisiae genome

Expression of the rDNA-encoded mitochondrial protein Tar1p is stringently controlled and responds differentially to mitochondrial respiratory demand and dysfunction

Toward a comprehensive temperature-sensitive mutant repository of the essential genes of Saccharomyces cerevisiae

A novel mitochondrial protein, Tar1p, is encoded on the antisense strand of the nuclear 25S rDNA.

Endosome to Golgi retrieval of the vacuolar protein sorting receptor, Vps10p, requires the function of the VPS29, VPS30, and VPS35 gene products.

Yeast vectors for the controlled expression of heterologous proteins in different genetic backgrounds

The challenge of improved secretory production of active pharmaceutical ingredients in Saccharomyces cerevisiae: a case study on human insulin analogs.

Large-scale mutagenesis of the yeast genome using a Tn7-derived multipurpose transposon.

Large-scale high-efficiency yeast transformation using the LiAc/SS carrier DNA/PEG method.

P31

scholarly article

P356

10.1093/FEMSYR/FOW104

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jorg C de Ruijter

Alexander D Frey

P577

2016-12-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27956492

http://www.w3.org/2001/XMLSchema#string